Showing results (411-420 of 598) with videos related to
Sort By:
Pageof 60
Neurosurgery|May 24, 2003
Basal ganglia neuronal discharge in primary and secondary dystonia in patients undergoing pallidotomyManjit K Sanghera, Robert G Grossman, Christopher G Kalhorn, et al.Journal of Neurochemistry|September 3, 2003
Role of nitric oxide in rotenone-induced nigro-striatal injuryYi He, Syed Z Imam, Zaojun Dong, et al.Journal of Neurochemistry|May 21, 2015
Rotenone affects p53 transcriptional activity and apoptosis via targeting SIRT1 and H3K9 acetylation in SH-SY5Y cellsYa Feng, Te Liu, Su-Yan Dong, et al.Neuro-Signals|July 23, 2011
Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson's diseaseYuncheng Wu, Xinqun Li, Julie Xiaohong Zhu, et al.Turkish Journal of Medical Sciences|November 16, 2019
Multicenter study of levodopa carbidopa intestinal gel in Parkinson’s disease: the Turkish experienceMurat Gültekin, Çağri Ulukan, Sabiha Tezcan, et al.Journal of the Neurological Sciences|August 8, 2008
Decreased NURR1 gene expression in patients with Parkinson's diseaseWeidong Le, Tianhong Pan, Maosheng Huang, et al.Neurogenetics|May 23, 2003
Haplotype analysis of the ETM2 locus in familial essential tremorJoseph J Higgins, Joseph Jankovic, Roni Q Lombardi, et al.Proceedings of the National Academy of Sciences of the United States of America|August 23, 2018
Local field potentials of subthalamic nucleus contain electrophysiological footprints of motor subtypes of Parkinson's diseaseIlknur Telkes, Ashwin Viswanathan, Joohi Jimenez-Shahed, et al.Archives of Neurology|February 16, 2006
Heterogeneous phenotype in a family with compound heterozygous parkin gene mutationsHao Deng, Wei-Dong Le, Christine B Hunter, et al.Nature Genetics|December 24, 2002
Mutations in NR4A2 associated with familial Parkinson diseaseWei-Dong Le, Pingyi Xu, Joseph Jankovic, et al.Pageof 60